Back to REGN
STATE STREET CORP REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
12
Latest value
$3B
Q2 2026
Peak value
$5.2B
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $4.3B |
| Q1 2024 | $4.7B |
| Q2 2024 | $5.1B |
| Q3 2024 | $5.2B |
| Q4 2024 | $3.4B |
| Q1 2025 | $3B |
| Q2 2025 | $2.5B |
| Q3 2025 | $2.6B |
| Q4 2025 | $3.6B |
| Q1 2026 | $3.6B |
| Q2 2026 | $3B |
| Q2 2026 | $3B |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $3B | 4.83M | — | — |
| Q2 2026 | $3B | 4.83M | — | — |
| Q1 2026 | $3.6B | 4.66M | — | — |
| Q4 2025 | $3.6B | 4.66M | — | — |
| Q3 2025 | $2.6B | 4.69M | — | — |
| Q2 2025 | $2.5B | 4.83M | — | — |
| Q1 2025 | $3B | 4.79M | — | — |
| Q4 2024 | $3.4B | 4.83M | — | — |
| Q3 2024 | $5.2B | 4.90M | — | — |
| Q2 2024 | $5.1B | 4.84M | — | — |
| Q1 2024 | $4.7B | 4.84M | — | — |
| Q4 2023 | $4.3B | 4.90M | — | — |
Other funds holding REGN
$6.2B
$5.7B
$4.7B
$4.5B
$3.5B
$3.4B